A detailed history of Sg Americas Securities, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 35,206 shares of ARWR stock, worth $703,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,206
Previous 9,369 275.77%
Holding current value
$703,415
Previous $244,000 179.51%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$19.36 - $29.54 $500,204 - $763,224
25,837 Added 275.77%
35,206 $682,000
Q2 2024

Jul 12, 2024

BUY
$21.87 - $28.24 $44,046 - $56,875
2,014 Added 27.38%
9,369 $244,000
Q1 2024

May 06, 2024

SELL
$27.21 - $39.48 $744,601 - $1.08 Million
-27,365 Reduced 78.82%
7,355 $210,000
Q4 2023

Jan 12, 2024

SELL
$21.2 - $31.03 $1.99 Million - $2.91 Million
-93,720 Reduced 72.97%
34,720 $1.06 Million
Q3 2023

Oct 13, 2023

BUY
$26.2 - $36.08 $2.63 Million - $3.62 Million
100,234 Added 355.36%
128,440 $3.45 Million
Q2 2023

Jul 10, 2023

BUY
$25.16 - $41.38 $507,175 - $834,138
20,158 Added 250.47%
28,206 $1.01 Million
Q1 2023

Apr 28, 2023

SELL
$23.68 - $38.51 $393,230 - $639,497
-16,606 Reduced 67.36%
8,048 $204,000
Q4 2022

Feb 02, 2023

SELL
$28.0 - $40.56 $480,592 - $696,171
-17,164 Reduced 41.04%
24,654 $1 Million
Q3 2022

Oct 31, 2022

SELL
$29.63 - $48.31 $2.26 Million - $3.68 Million
-76,196 Reduced 64.57%
41,818 $1.38 Million
Q2 2022

Jul 29, 2022

BUY
$27.79 - $50.61 $436,886 - $795,639
15,721 Added 15.37%
118,014 $4.16 Million
Q1 2022

Apr 29, 2022

SELL
$39.62 - $69.97 $1.11 Million - $1.97 Million
-28,108 Reduced 21.56%
102,293 $4.7 Million
Q4 2021

Feb 07, 2022

BUY
$58.09 - $82.51 $340,639 - $483,838
5,864 Added 4.71%
130,401 $8.65 Million
Q3 2021

Nov 01, 2021

BUY
$58.38 - $84.96 $619,645 - $901,765
10,614 Added 9.32%
124,537 $7.78 Million
Q2 2021

Aug 12, 2021

BUY
$62.15 - $90.32 $3.66 Million - $5.32 Million
58,890 Added 107.01%
113,923 $9.44 Million
Q1 2021

May 13, 2021

BUY
$61.35 - $90.47 $994,115 - $1.47 Million
16,204 Added 41.73%
55,033 $3.65 Million
Q4 2020

Feb 04, 2021

SELL
$43.82 - $85.37 $411,645 - $801,965
-9,394 Reduced 19.48%
38,829 $2.98 Million
Q3 2020

Nov 09, 2020

BUY
$33.21 - $51.27 $209,853 - $323,975
6,319 Added 15.08%
48,223 $2.08 Million
Q2 2020

Jul 20, 2020

SELL
$26.12 - $43.27 $25,571 - $42,361
-979 Reduced 2.28%
41,904 $1.81 Million
Q1 2020

Apr 30, 2020

BUY
$20.56 - $63.12 $454,725 - $1.4 Million
22,117 Added 106.51%
42,883 $1.23 Million
Q4 2019

Jan 28, 2020

SELL
$28.14 - $73.01 $1.75 Million - $4.54 Million
-62,239 Reduced 74.98%
20,766 $1.32 Million
Q3 2019

Nov 04, 2019

BUY
$26.26 - $34.86 $1.54 Million - $2.04 Million
58,527 Added 239.1%
83,005 $2.34 Million
Q2 2019

Jul 29, 2019

BUY
$17.43 - $28.82 $327,509 - $541,527
18,790 Added 330.34%
24,478 $649,000
Q1 2019

Apr 29, 2019

SELL
$12.05 - $20.18 $92,327 - $154,619
-7,662 Reduced 57.39%
5,688 $104,000
Q4 2018

Feb 01, 2019

BUY
$10.74 - $19.7 $143,379 - $262,995
13,350 New
13,350 $166,000
Q4 2017

Jan 24, 2018

SELL
$3.14 - $4.5 $34,389 - $49,284
-10,952 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$1.69 - $4.33 $18,508 - $47,422
10,952
10,952 $47,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.